The embolization particle market size is estimated to be USD 1,438.1 million in 2021 and is expected to witness a CAGR of 11.70% during the forecast period 2022-2032. The rising need for embolization particles for interventional cardiovascular procedures & interventional radiology, improvements in embolization particle technology and rising demand for minimally invasive procedures are factors contributing to the market growth. However, lack of interventional neuroradiologists and interventional neuroradiology (INR) labs, stringent regulations, and risks including coagulation of vital veins and blood supply is expected to hinder the growth.

Segmentation

By Product

Based on product, the market is categorized into drug eluting beads, microspheres, radioembolization spheres, and others. In 2021, the radioembolization spheres accounted for the highest revenue share due to its application in the treatment of cancer, the radioembolization particles category.

By Application

On the basis of application, the market is categorized into neurology, peripheral vascular disease, urology, oncology, and others. In the global market, the oncology segment accounted for the largest revenue share in 2021 owing to the growing use of embolization particles in cancer therapies.

By End User

Based on end user, the market is segmented into clinics, ambulatory surgical centers, and hospitals. In 2021, the hospitals segment accounted for the largest revenue share owing to the fact that many hospitals are utilising embolization particles for a variety of treatments

Regional Markets

In 2021, North America region accounted for the highest revenue in the embolization particle market and is expected to maintain its dominance during the forecast period. This is attributed to the its modern hospital infrastructures and accessibility to qualified medical professionals. Strong economic conditions and significant healthcare industry development are further boosting the market’s expansion. Additionally, among the other areas, Asia Pacific is predicted to develop at the quickest rate due to the factors like changing lifestyles, the rising incidence of cancer among the elderly population, and the increased focus on early detection and treatment of cancer.

Competitor Insights

Some of the key players operating in the embolization particle market are Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, Interface Biomaterials B.V. and Alicon among others.

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including product, application, and end user from 2021 to 2032.

Report Scope:

Segmentation: Embolization Particle Market Report 2021- 2032

Product (Revenue, USD Million)

• Drug Eluting Beads
• Microspheres
• Radioembolization Spheres
• Others

Application (Revenue, USD Million)

• Neurology
• Peripheral Vascular Disease
• Urology
• Oncology
• Others

End user (Revenue, USD Million)

• Clinics
• Ambulatory Surgical Centers
• Hospitals

By Region (Revenue, USD Million), 2022 – 2033

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA